Tennessee Academy of ScienceDistinguished Secondary School Science Teacher Award 2022

Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Tennessee Academy of Science Executive Committee Meeting Minutes, November 2021. Journal of the Tennessee Academy of Science 1 December 2021; 96 (1): 11–17. doi: https://doi.org/10.47226/96.1.11 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search

Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Tennessee Academy of Science Executive Committee Meeting Minutes, May 2020. Journal of the Tennessee Academy of Science 1 December 2021; 96 (1): 1–3. doi: https://doi.org/10.47226/96.1.1 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search

International Society of Nephrology

Adapting Scientific Conferences to the Realities Imposed by COVID-19.

From demanding greater executive accountability to lobbying for social and environmental policies, shareholders today influence how managers run American companies. In corporate doctrine, the principal venue reserved for shareholders to exert their influence and engage with management and each other is the annual shareholders meeting. At one time the annual meeting was a vibrant forum for shareholder democracy and occasionally even a platform for debating pressing social issues. For decades, however, the role of the annual meeting in corporate governance has been in decline. Today’s annual meetings are largely pro forma: only a handful of shareholders attend the meeting and voting results are largely determined in advance. This Article explores how the integration of technology can resurrect the annual meeting as the deliberative touchstone of shareholder democracy it once was as well as open new avenues for engagement. The widespread use of virtual annual meetings in response to COVID-19 provides an opportunity to critically rethink and re-envision the practice and purpose of the annual meeting. If structured properly, virtual meetings can re-engage historically absent shareholder demographics while maintaining the efficiencies of proxy voting. Additionally, virtual meetings can serve as vehicle through which companies can begin to address ESG issues and heightened public expectations that companies will work toward meaningful engagement with their varied stakeholders. This Article makes three key contributions to the existing literature. First, it provides a detailed account of state reactions to COVID-19 and of the impact that the move to virtual meetings had on shareholder voting. Second, it provides a detailed account of how annual meetings have drifted away from their democratic function. Finally, this Article argues that technology can revive shareholder democracy and bolster ESG efforts through facilitating retail shareholder and corporate stakeholder engagement, and underscores how virtual meetings can meet these important goals.

American Association for Thoracic Surgery: Maintaining the mission during the coronavirus disease 2019 (COVID-19) pandemic

Legacies begun, legacies continued

Driving change and elevating the level of practice

EditorialPhysiological Societies Across the Globe Unite in an Effort to Handle the COVID-19 PandemicSusan M. Barman, László Csernoch, and Jayasree SenguptaSusan M. BarmanMichigan State University, East Lansing, MichiganVice Chair, Board of the General Assembly, … See all authors Published Online:17 Feb 2021https://doi.org/10.1152/physiol.00001.2021MoreFiguresReferencesRelatedInformationPDF (86 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookXLinkedInWeChat The year 2020 will forever be cast in a negative light because of the coronavirus infectious disease (COVID-19) pandemic that changed everyday life globally, with nearly 220 countries and territories experiencing its devastating impact. As 2020 came to an end, based on the data supplied by the World Health Organization, the novel coronavirus had infected over 81 million people worldwide and nearly 1.8 million people had died because of complications of COVID-19 (1). These numbers continue to grow at alarming rates. Whole countries or states across the globe have enacted rules designed to limit the spread of the virus by requiring inhabitants to stay home and adhere to social distancing; nonessential businesses have closed their doors, including restaurants, theaters, performing arts centers, barber shops, health clubs, and even churches. In many cases, schools have changed to online learning or at least markedly limited face-to-face activities; many youth, college, and professional sporting events have been canceled; and national and international travel has been curtailed. In many places, science laboratories were shuttered for months. The changes in life precipitated by COVID-19 have the potential to change human behavior forever and have certainly changed the everyday life of biomedical researchers and educators (2). Despite the global anxiety posed by the novel coronavirus, a bright spot is how it brought together teams of scientists across the globe who cooperated to develop treatments that hopefully will help to bring an end to fatalities linked to the pandemic (3). Remarkably, by the time 2020 came to an end, several manufacturers (Pfizer-BioNTech, Moderna) had begun to release vaccines in multiple countries with high efficacy to control the devastating actions of the virus that causes COVID-19 (4). In fact, there are over 50 candidate vaccines under development globally, allowing us to see at least a glimpse of that proverbial "light at the end of the tunnel." In late summer 2020, the Board of the General Assembly of the International Union of Physiological Sciences (BGA/IUPS) reached out to member societies to gather information on the impact of the COVID-19 pandemic on their society operations and the activities of their members. Feedback was received from 25 physiological societies representing Africa, the Americas, Asia, Europe/European Union, the Mideast, and Oceania. Table 1 and Table 2 capture the responses received to two pointed questions, respectively:Table 1. How has COVID-19 impacted the functioning of your Society?Member OrganizationResponseAmerican Physiological SocietyThe most obvious functional impact was the almost complete shutdown of our main headquarters in Rockville, MD for several months. The entire operation was transformed into a virtual effort; this is ongoing. We anticipate that a large part of the operation will continue in virtual mode into 2021. Some of our colleagues will continue working remotely for the foreseeable future. A survey revealed that a large percentage of staff find they can work efficiently from home, and our significant achievements during the pandemic have confirmed that this is the case. The absence of major commuting time for many staff residing in the Washington DC area has played a major role in this increase in efficiency, a positive impact of the pandemic.From a member point of view, we have achieved, and in many cases exceeded, the goals laid out in our last strategic plan, despite the pandemic. Interactions with member leaders on APS council, committees, in the sections, and in publications areas have continued with little disruption.The pandemic has also pushed APS more quickly than anticipated into the virtual meetings arena. In the past few months, we have hosted highly successful scientific and education meetings, webinars, town halls, and career development programs in which thousands of members have participated—many more, in fact, than for the equivalent live sessions at face-to-face meetings. The cancellation of our major meeting of the year at Experimental Biology (EB) was a difficult decision made in the early stages of the pandemic, in January, but turned out to be wise and necessary in retrospect. While the time frame of this decision did not allow us to replace EB fully in April 2020, we did organize a limited number of sessions online that were very well attended and received by our members. The 2021 EB meeting is also virtual, but the long lead-up time has allowed us to organize a more complete virtual meeting, using a professional online platform, with the other contributing societies that normally participate in EB.One positive effect of the new virtual life of APS is that we can serve our international members more effectively. Since our leadership meetings are virtual, it is now possible to envisage increasing the international representation in these efforts by, among other considerations, carefully taking account of geographic diversity and international time zones during the organization process.Another positive effect of the pandemic is that potential budget shortfalls (e.g., reduced journal subscription revenue, reduced meeting registration income) have been to some extent balanced by a large reduction in travel and associated costs normally expended to assemble committee members and leaders for a variety of meetings. It is likely that reduced travel expenses will be a permanent feature of our budgeting even when we move out of pandemic mode.Australian Physiological SocietyThe major impact has been the cancellation of our major events such as the 2020 Annual Scientific Meeting and our PhD research training award (a 2-day onsite research training event). This has deprived all our members of valuable opportunities to present their research and to network.Council has continued to function mostly unhindered, with twice-yearly Council meetings being moved from in-person to online.Our Annual General Meeting of all members is this year planned to be held online.Bangladesh Society of PhysiologistsLike other organizations, in this pandemic-induced lockdown, the Society activities are affected. Seminars and the meeting of the Society have been postponed.Very limited conversation regarding society activities has been made over the telephone as all the senior members are forced to stay home for health risk.By arranging Zoom meetings, efforts for regular meetings of the Society have been made to maintain the activity in a very limited scale.Despite this adverse situation, the Society successfully published its journal within the stipulated time.Bulgarian Society for Physiological SciencesSociety members write and publish articles how to fight the still ongoing COVID-19 pandemic such as the recently published review, "Emerging Neurological and Psychobiological Aspects of COVID-19 Infection" in Brain Sciences 2020, vol. 10, issue 11, 852, doi:10.3390/brainsci10110852.For the 3rd Conference "Neurosciences—from Theory to Experiment and Practice," held in the University Campus Bachinovo of South-West University in Blagoevgrad, Bulgaria 23–25 October 2020, all participating physiologists dedicated a special meeting discussing the challenges of COVID-19 pandemic and how to counteract it.Canadian Physiological SocietyWe held our first official Society symposium in May 2019 after 7–8 yr without having a meeting. We hoped to continue with this by hosting another symposium in May 2020, but this had to be cancelled due to lockdowns in Canada.Overall, the main objective of the Society has been to work towards re-energizing a national community for physiology, with a focus on sponsoring trainee activities.Our primary planning activities have been to look ahead towards late 2021, when we hope we can continue with symposium organization and other trainee activities.Chilean Society of Physiological SciencesThe Society's annual meeting was cancelled, but we managed to run the 2020 annual meeting in a virtual form. This activity has been very well valued.To open our region to Latin America researchers in physiology, we decided to have our 2020 annual meeting as a joint meeting with the Latin American Association of Physiological Sciences. We had more than 650 registered scientists for the meeting. This collaborative activity was a perfect platform for young researchers to show their data and establish new contacts with not only physiologists from LA but from all continents.Since March, the monthly meetings of the directory board of the Society have been virtual meetings, and the Society operations were unaltered. Our general feeling is that it was helpful to meet without the typical problems finding a suitable place and time to meet.The Society organizes regular selected seminars that have been cancelled since March. Mainly because we, as researchers and teachers, were involved in a new way to conduct these two activities virtually. This is a major weakness since there was not an option for interacting and establishing networks by meeting, talking, and discussing with the speaker.Chinese Association for Physiological SciencesThe COVID-19 had quite a negative impact on the routine operation of our Society in the beginning. Luckily, we transformed and advanced the management in terms of the operation. For instance, we have adopted the online application system for the review and approval of all the documents.The Zoom Cloud Meetings system has been used for our online meetings weekly so that all our directors and colleagues could easily communicate with each other, especially during the COVID-19 period.Chinese Physiological Society in TaipeiThe election of new Society council members was conducted through voting by post instead of our usual vote in-person due to the cancellation of our annual joint conference with other societies in March.Our council meeting was also conducted through web meeting to avoid gathering.Although the large-scale joint conference in Taipei was cancelled in March, another scientific meeting and teaching workshop hosted by the Society took place for our members in August 2020.We are watching closely with strict precautions to adjust the schedule for our council meetings in 2020/2021.Overall, the Society has functioned regularly with minimal obstacles due to COVID-19.Cuban Society of Biomedical Basic Sciences (formerly Cuban Society of Physiological Sciences)The Society had to respond and adapt to the COVID-19 pandemic and its impact on academic and clinical instruction. Most of the preclinical conferences and scientific meetings were substituted by "online" activities.Revista Cubana de Investigaciones Biomédicas continues its work as usual. The editorial staff works at home to produce the journal that is now first among the Cuban scientific journals according to the last Scimago Journal Rank and is third among the Cuban journals in Google Scholar because of the number of received citations.Finnish Physiological SocietyIn Finland, emergency conditions were declared due to the COVID-19 pandemic in March 2020. This meant the closure of the Society, travel bans, and isolation.The Society had to hold its annual meeting on short notice as a remote meeting. To guarantee its legitimacy, the Governmental umbrella organizations of the scientific societies quickly made the necessary changes to the rules.The Society changed its scholarship policy so that instead of congress trips, scholarships were also awarded for other purposes.Grants to be used in 2020 were transferred for use in 2021 without a separate application. The Society moved to continuous application policy instead of fixed dates.French Society of PhysiologyCOVID-19 impacted our Society at the organizational level. However, we have overcome this unprecedented situation. We have organized the meetings of Scientific and Administrative Councils via Zoom.We are going to organize, via internet call system, the annual General meeting. As is the case for most of the national and international Congresses, we postponed the annual Congress of the Society that was scheduled for June 2020.German Physiological SocietyAll meetings in 2020 (i.e., Europhysiology2020 and the annual meeting of the young physiologists) were cancelled.All society board meetings were transformed to online meetings.We plan online meetings for young physiologists, the general assembly of our society, as well as "a day of physiology" covering research aspects for October 2020.Iranian Society of Physiology and PharmacologySince starting the COVID-19 pandemic, we increased our communications with the members in virtual space through websites, channels, e-mails, etc. to share information and new findings.The Society has encouraged physiologists and pharmacologists to design research projects about COVID-19, especially on the virus deleterious effects on the body physiology and potential treatments.We have also published a weekly newsletter to provide an overview of the COVID-19 situation in Iran and the world with the latest scientific news.Israel Society of Physiology and PharmacologyWe had to cancel a big meeting, and we are unsure if we can conduct our annual meeting.Life Science Switzerland (LS2)-PhysiologyWe had to adapt quickly to the pandemic situation and to cope with the COVID-19 crisis.We could not have our annual meeting on-site as planned, but we updated the program to offer an online version and to include extra short talks to increase the knowledge exchange among participants: https://meetings.ls2.ch/physiology2020.Physiological Society of IndiaThe Society organized the following five national webinar-based awareness programs against the ongoing COVID-19 pandemic:Dept. of Sports Science, University of Calcutta; 21 August 2020 via Stream Yard and YouTube; Effect of Yoga in Sports Performance during COVID-19Dept. of Physiology, Midnapur College (Autonomous), Midnapore, West Bengal organized 1-day program; 29 August 2020; Development & Maintenance of Physical & Mental Wellness during COVID-19 PandemicDept. of Sports Science, University of Calcutta; Application of Biomechanics in Sports Performance—A COVID-19 PerspectiveDept. of Sports Science, University of Calcutta; 20 September 2020; Exercise Program and Nutritional Supplement to prevent COVID-19 and other viral infectionsDept. of Physiology, Berhampur Girls' College, Berhampur, Murshidabad, West Bengal; 25–27 September 2020; Three-Day National Webinar on COVID-19: Fighting Together and Moving ForwardPhysiological Society of JapanThe 97th Society Annual Meeting was Mar 17–19, 2020; the outbreak of COVID-19 occurred at the final stage of the meeting preparation. The meeting presidents made a courageous decision at the last minute to give up the on-site meeting, and to hold only in the presentation abstract issue of the official society journal, The Journal of Physiological Sciences. The council meeting and the general assembly were held in a hybrid style of on-site and online.The 98th Annual Meeting is scheduled for Mar 28–30, 2021. In Oct 2020, the meeting presidents decided to hold the meeting online.Physiological Society of NepalThe biggest impact of the COVID-19 on the Society and our members is the financial aspect. All our members are employed as physiology teachers in various medical colleges in the country. With the closure, the colleges adopted a "no work no pay" policy for the first few months. However, lately, most colleges have started to give salaries, but heavily reduced.The theory classes of the undergraduate courses are being conducted online. Some brief orientation and training were conducted to familiarize teachers to such methods.Because travel and movements are restricted, our members have been mostly confined to home. Research labs and works have stopped altogether.Our Society's regular meetings are on hold, and previously planned symposia, conference have been postponed indefinitely.Physiological Society of NigeriaOrdinarily, the Society Annual Scientific Conference and Annual General Meeting occur between the months of August and September. Due to the COVID-19 pandemic, we had to postpone the conference to next year, when it is hoped the situation will be better. The Society is considering the possibility of hosting the AGM through an online mode.In the last 6 mo, higher institutions have been closed. Members of the Society have had to work from home, and this has affected negatively teaching and research.Physiological Society of New ZealandOur major activity is to run our annual meeting, which is part of a larger professional society meeting called MedSciNZ. This year's meeting was cancelled, but we held a virtual meeting which was transformed into an awards symposium that was held over 2 half days. This symposium was formatted to allow us to present our student, emerging researcher, and early career researcher awards, plus our triannual medal for excellence in physiological research that is awarded to an established physiologist.We have resorted to running the Society via virtual Council meetings and have a virtual Annual General Meeting scheduled for mid-October.Slovak Physiological SocietyFortunately, we just managed to organize the annual meeting of the Society in February 2020 before the pandemic strike.Other smaller events with participation of our Society had to be cancelled.Committee meetings and correspondence (e.g., evaluation of the best posters at the annual meeting and the best publication 2019 of the Society members) are done electronically.Slovenian Physiological SocietyDespite the COVID-19 crises, the Society is active. We have organized in September a general assembly meeting via the videoconference Cisco Webex platform.On 10 December 2020 we are organizing the annual society meeting.The Day of Physiology 2020, which takes place each year on the day the Nobel Prize in Physiology or Medicine is awarded. We will have and for the general teachers, members of the Society, etc. on physiology of with the focus on and virus physiology and the COVID-19 pandemic. The meeting will place via videoconference using the Zoom Society of Physiological to COVID-19 the meeting of our Society, planned to be held at in October 2020, had to be and has been postponed for 2020 was this Physiological SocietyWe established a COVID-19 to provide an of the physiological and this disease with the of from during the social and our we have a hosting our including and our We the work of our members in the COVID-19 pandemic to the and organizations such as Health can be at training courses and and on a for the management of have financial to members in the most difficult of financial from have run two professional development for together from across the physiological from an academic and career to give and on areas such as social and Journal of Physiology Journal is a platform for physiologists to meet on a regular to that have been published in the Journal of Physiology and Experimental Physiology are to all research to a that the a to bring together a of to people through the and and over the can be at Association of Physiological were affected by We could not organize the National Physiology Congress and other Society managed to publish a Physiology members of the Society to the 1. How has COVID-19 impacted the functioning of your How has your Society its members to with the impact of COVID-19 on their teaching and OrganizationResponseAmerican Physiological part of our information the September issue of The was dedicated to the COVID-19 pandemic. We published articles on a of community during the pandemic, an with a member including how the pandemic has affected two articles about the physiology of the virus and and an about efforts being made on the and of a APS members to share their via and by We published a of these in the September issue of The transformed a of our into a COVID-19 that and scientific and to the pandemic. The information helpful and on pandemic-induced changes in work style and career such as with during the pandemic, and how to when are working from home. It also information on involved as a to help society and science in various during the pandemic, up to and including being a have moved of our operation to virtual, allowing members to participate in a variety of activities during the from scientific meetings and to career development programs and routine meetings such as committees, working and the in Physiology we a program to provide financial to who help they virtual events have an ongoing survey of our members how the pandemic has affected their research and It has not been and Physiological SocietyWe have to online meetings for and early career members and for physiology educators to present their increased the of our PhD to some of our best researchers to conduct their research in the COVID-19 Society of members of the Society are efforts to continue the academic activity and in the situation of took to overcome the obstacles and cope with the situation by of internet has used the to the and maintain the The platform has been used to run the undergraduate Physiology education are running without but it is very difficult to for are involved in with their clinical colleagues they are an role in COVID-19 Society for Physiological physiologists participate in research projects the COVID-19 pandemic such as of and for the of COVID-19 in an of in and of for of coronavirus and vaccines for of in in awareness from physiologists on a COVID-19 pandemic is and how to prevent it is going to a member of the Society, for and on and about the COVID-19 pandemic and how to Society of Physiological to run the annual meeting in a virtual This is that our members to show their Society for to all members with (i.e., or several aspects of the pandemic. We had a from members and in and other several regarding this on the members did not have the option to be in their labs for the last many and starting their research projects were to data to communicate at the annual meeting of the We the possibility for to present at the meeting under the of This was a way for to show their research and organized several online activities; they for from the We by it as as possible on the web and has been transformed with the pandemic. The Society its members to adjust to the new way to The to the members has been short and with time between evaluation as a of the or This was in the 2020 annual meeting of the Society and was well received by Association for Physiological have been our best to our members in the impact of COVID-19 on their to more for their and to more opportunities for their best of teaching and training for our members during the pandemic we have a of and especially for undergraduate and education in the physiological International for Physiological was organized by our Society in late April as the first conference to provide a platform for our physiological education community to share for the physiological teaching during the spread of online International was held in early with the of and of physiology teaching in the post COVID-19 with talks and having about how to with the impact of COVID-19 on physiological we had successfully our 2020 Annual Conference that not only the latest to physiological researchers but also about teaching and training with our members from the physiology education We have encouraged the to publish more research articles on COVID-19 since our Society is of the of this for teaching and the of physiology and physiologists in this year our Society has also up the science in the Physiological Society in there is some by COVID-19, still normally to maintain academic Society has a new International and Physiology to for The is by young in their early career and the committee is by of the council members in The among members is mostly done in and meetings.We have our society members and for their regarding of help they from the Society to their and career development during that to be held by COVID-19 is the education of our and knowledge in physiology which is the that medical Society of Biomedical Basic Sciences (formerly Cuban Society of Physiological are many activities in across the Cuban and research and from the and other have used to develop and for health clinical in which the medical are involved include evaluation of new Cuban

PPAG is pleased to announce the 2013 FPPAG Inductees. Fellows in the Pediatric Pharmacy Advocacy Group (FPPAG) are recognized for distinguished professional accomplishments in pharmacy practice, research, and education as well as service to the pediatric pharmacy profession, especially PPAG.The new Fellows was introduced during the 22nd PPAG Annual Conference on May 3, 2013 in Indianapolis, IN.Kimberley Benner, PharmD, BCPS, FPASHP, FPPAG has had a significant impact on pediatric pharmacy practice through her education, research, and service. Dr. Benner is a Professor at the Samford University McWhorter School of Pharmacy and a Pediatric Clinical Specialist at Children's of Alabama in Birmingham. Dr. Benner graduated with her Doctor of Pharmacy degree from Samford University and completed an ASHP-accredited residency at Children's Hospital in Birmingham. Dr. Benner's research interests and areas of publication include pediatrics, infectious diseases, pharmacy and simulation education. Dr. Benner is currently serving as the Chair of the PPAG research committee after having been a member since 2006. She has attended many PPAG meetings and provided educational programs, including poster presentations. She frequently serves as a poster judge and abstract reviewer and was on the fundraising committee.Dr. Benner has been in academia since 1997 and has precepted numerous students through pediatric clinical and academic rotations. Dr. Benner rounds daily at the Children's Hospital. She has contributed to the scientific knowledge of caring for pediatric patients through her numerous presentations at local, state, national and international venues. Her work typically is from the critical care unit and provides practical information needed to care for the sickest children, including her most recent publication in which she was the primary author on ASHP's position statement on the use of 0.9 saline for indwelling catheters. Dr. Benner not only presents for the pharmacy practitioners, but extends her work into the medical literature which strengthens the profession of pharmacy as a whole. Notably, Dr. Benner has served as an evaluator for the 2010–11 Best Pharmaceuticals for Children Act (BPCA) Priority List of Needs in Pediatric Therapeutics.Michael Christensen, PharmD, FPPAG has been directly involved in the evolution of the regulatory process in increasing pediatric labeling for dozens of drugs on the USA market. He was Associate Director for the PPRU at UTHSC and Le Bonheur Children's Medical for 10 years, and was the innovator that created the Pediatric Clinical Trial Unit at Le Bonheur. He has directly overseen hundreds of clinical trials in children, involving dozen of medications. His work has contributed our understanding of drug use in children with obesity, type II DM, pain management, cardiovascular disease, sedation, liver disease, and much more. He is among the most knowledgeable clinicians in the country in metabolism and nutrition support.Dr. Christensen received his B.S. in Pharmacy from North Dakota State University in 1978 and a Pharm.D. from the University of Tennessee in 1982. He completed a residency in pediatric pharmacotherapy at LeBonheur Children's Medical Center and a fellowship in pharmacokinetics and pharmacodynamics at St. Jude Children's Research Hospital. Dr. Christensen spent 6 years at St. Jude Children's Research Hospital as a clinical pharmacist and developed the metabolic support service. In 1990 Dr. Christensen joined the full-time faculty at the University of Tennessee, College of Pharmacy. Dr. Christensen is a board certified nutrition support pharmacist and served of the Board of Pharmaceutical Specialties Specialty Council on Nutrition Support Pharmacy for 6 years. From 1994 to 2003 he was the Co-Director for the Pediatric Pharmacology Research Unit funded by the NIH and directed the Children's Foundation Research Center Pediatric Clinical Research Unit until 2011. In 2012 Dr. Christensen was appointed as an Associate Vice Chancellor for Research. Dr. Christensen has more than 130 published articles, book chapters and abstracts. His research interests include pharmacokinetic and pharmacodynamic studies of drugs in infants and children as well as the metabolic and nutrient requirements in infants.Dr. Christensen has given of his considerable talent and treasure to PPAG over the last 10 years. His leadership roles including being President, Board member, speaker and a loyal supporter of the organization.Carlton K.K. Lee, PharmD, FPPAG Dr. is one of the nation's most respected pediatric Pharm.D's. His consistent and superb work as the editor of the Harriet Lane Handbook Formulary Section is one of his most visible accomplishments. The Harriet Lane Handbook is a national reference for all pediatricians beginning with their intern year and continuing throughout their career. Dr. Lee has helped shape the quality pediatric program at John Hopkins over the last 20 years. He has been instrumental in implementing a number of programs that have made the clinical services on par with other outstanding program in the country. This includes the development of of a pediatric pharmacy residency program as well. Simply without Carlton, it hard to imagine the program at Johns Hopkins to be as progressive as it today.Dr. Lee is the Clinical Pharmacy Specialist in Pediatrics for The Johns Hopkins Hospital, Associate Professor in Pediatrics for The Johns Hopkins University School of Medicine and Clinical Professor with the University of Maryland School of Pharmacy. Dr. Lee developed and continues to serve as the Residency Program Director for the PGY-2 Pediatric Pharmacy Specialty program.Dr. Lee received his Doctor of Pharmacy degree from the University of the Pacific and Masters in Public Health from The Johns Hopkins University Bloomberg School of Hygiene and Public Health. He completed a General Hospital Pharmacy residency at The Johns Hopkins Hospital and Pharmacokinetics/Pharmacodynamics Fellowship at The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Dr. Lee began his career at Johns Hopkins as a Neonatal clinical pharmacist. He became the Senior Clinical Pediatric and Pediatric Clinical Coordinator in 1988 and 1990, respectively, at Hopkins. Dr. Lee has over 25 years of Pediatric Clinical Pharmacology experience with teaching responsibilities to pharmacy and medical residents and students. His clinical research experience have been in Phase I/IV pharmacokinetic/drug development studies in Cystic Fibrosis and HIV/AIDS; and developing safe tools for Pediatric Outpatient Prescribing.Dr. Lee has published several articles and medical text chapters; most notably, he is the editor to the Formulary section to the Harriet Lane Handbook for the past 22 years. He has lectured in numerous forums on Cystic Fibrosis and Pediatric Clinical Pharmacology on the local, national and international levels. Dr. Lee has been honored to have mentored 20 PGY-2 Pediatric Pharmacy residents. Recognition of his efforts includes:- Fellowship in the American Society of Health System Pharmacists - Who's Who in America, the East, Medicine & Healthcare, Science & Engineering, and the World. Dr. Lee has served on the Board of Directors to the Pediatric Pharmacy Advocacy Group. He had also established a non-profit Pediatric Pharmacy continuing education corporation entitled the Mid-Atlantic Pediatric Pharmacotherapy Specialists.Stephanie Phelps, BSPharm, PharmD, BCPD, FPPAG is one of the most influential pediatric pharmacists in the country. In addition to paving the way for pediatric pharmacists in clinical practice, she is editor of “The Teddy Bear Book: Pediatric Injectable Drugs”, now in its ninth edition, which has become the definitive guide for the administration of injectable drugs in pediatric patients. She also serves as editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics.Dr. Phelps is among most knowledgeable pediatric clinicians in the country in epilepsy and the use of seizure medications. She has help define the use of new anti-seizure medications, and has contributed to clinicians understanding of use and treatment of seizure disorders through publication, education, and direct patient care.Dr. Phelps was born in August Georgia, but spent her formative years in Niceville, Florida -a small town in the pan-handle of the state. She attended high school and junior college in the area, before moving to Birmingham, Alabama to pursue a baccalaureate pharmacy degree from Samford University (‘79). She relocated to Memphis, Tennessee where she obtained a doctorate of pharmacy from The University of Tennessee ('82) and subsequently completed post-doctoral training in pediatrics at LeBonheur Children's Medical Center and The University of Tennessee. Dr. Phelps is currently a Professor of Clinical Pharmacy and Pediatrics at The University of Tennessee Health Science Center and Associate Dean of Academic Affairs for the College of Pharmacy. For over a decade, she served as Director, of Experiential Education of the College. She is an elected Fellow of ACCP and APhA and is a Board Certified Pharmacotherapy Specialist. Dr. Phelps has held elected offices in AACP and ASHP and has served on the Board of Directors of ASPEN and PPAG. She is the immediate past chair of the Pharmacy Academy of the National Academies of Practice, where she is a distinguished Practitioner and Fellow. She is a recipient of the 1999 APhA-Academy of Student Pharmacists Outstanding Chapter Advisor award, the 2009 Tennessee Society of Hospital Pharmacy's Distinguished Service Award and the 2011 Helms Award recipient for Excellence in Pediatric Pharmacy Practice by PPAG.Dr. Phelps has received numerous teaching awards and was the first pharmacy faculty member elected to the UTHSC campus Academy of Distinguished Teachers. During her career she has participated in the education of 5 postdoctoral fellows and over 60 pediatric pharmacy residents. She has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.Cathy Poon, PharmD, FPPAG helped shape some of the early changes in pediatric pharmacy in the Philadelphia area and has trained some of the most highly visable and successful pediatric pharmacists in practice today.Dr. Poon is Professor of Clinical Pharmacy with tenure of the Department of Pharmacy Practice and Pharmacy Administration and Vice Dean of the Philadelphia College of Pharmacy, University of the Sciences. She graduated from St. John's University with a Bachelor of Science in Toxicology and a Bachelor of Science degree in Pharmacy; and received her Doctor of Pharmacy degree from Medical University of South Carolina. Dr. Poon completed her Hospital Pharmacy Residency at the Medical University of South Carolina and a Specialty Residency in Pediatric Pharmacotherapy at University of Oklahoma Health Science Center.As an academician and clinician, Dr. Poon's primary area of interest and practice is pediatric pharmacotherapy. She practiced in the areas of neonatology, general pediatrics and pediatric critical care. Dr. Poon served as a program director and mentor for 11 pediatric pharmacy practice residents and one fellow over the past fifteen years. Her scholarship includes manuscripts published in pharmacy, medical and nursing journals, as well as serving as a review for several journals. Dr. Poon has conducted and collaborated in a number of clinical research projects related to pediatric pharmacotherapy. In addition to pediatrics, she is also passionate about developing collaborative health care education and practice programs with other healthcare professions. In addition to serving on pharmacy professional organizations, Dr. Poon was appointed by the Governor of Pennsylvania in 2006 to serve on the Advisory Health Board of the Commonwealth of Pennsylvania.PPAG is pleased to announce the new members of the Board of Directors and Executive Committee. These individuals will be joining incoming President Bill Maish, PharmD, Immediate-Past President Amy Potts, PharmD, and Directors-At-Large Jared Cash, PharmD, Michael Chicella, PharmD, Tracy Hagemann, PharmD, David Hoff, PharmD. Their term begin May 1, 2013.PPAG is governed by an eleven (11) member Board of Directors, consisting of five (5) Executive Committee members and six (6) Director-At-Large.Dr. Kyllonen is a Clinical Specialist in the Neonatal Intensive Care Unit at the Cleveland Clinic in Cleveland, OH.Dr. Kyllonen has been a member of PPAG for 15 years. She served as Secretary of PPAG this past year. She has served on the Board of Directors for the past two years, and the Education Committee for serveral years, and was the chairperson of the 2009 PPAG Annual Conference in Cleveland, OH. She received FPPAG recognition in 2009. She has presented during PPAG Annual Conferences.Jeff Low is the Clinical Pharmacist Specialist-Pediatrics at the Children's Hospital at Dartmouth.Dr. Low has served on the Board of Directors since 2006, and served as Chair from 2008–2009. Dr. Low has participated on the research & member services committees. From 2003–2005, he served as the Vice-President for Member Services, where he has worked on projects such as the PPAG website upgrades, membership survey, PPAG newsletter, and launching online CE.This will be Dr. Low's third term as Treasurer of PPAG. In this role, he oversees the internal audit, budget development, and fiscal evaluation of programs.Lisa Lubsch, PharmD is Clinical Assistant Professor in the Pharmacy Practice Department at the Southern Illinois University Edwardsville School of Pharmacy and Clinical Pharmacy Specialist at Cardinal Glennon Children's Medical Center. Dr. Lubsch received the B.S. and Doctorate of Pharmacy from the St. Louis College of Pharmacy and completed a pediatric specialty residency at the Texas Tech University Health Sciences Center School of Pharmacy. She currently provides pharmacist-delivered patient care to children on the pulmonary, cardiology, and a general medicine service. Her current areas of interests are pediatric asthma, cystic fibrosis, and addiction medicine.Dr. Lubsch served on the 2012–13 Board of Directors. Prior to her service on the Board, she served as Chair of the PPAG Education Committee. She also served as Chair of the 19th Annual PPAG Annual Meeting and Pediatric Pharmacy Conference in St. Charles, Missouri.Brady Moffett, PharmD is the Clinical Pharmacy Specialist for the Heart Center at Texas Children's Hospital and an Assistant Professor of Pediatrics at Baylor College of Medicine. He graduated from Purdue University and did residency at University of Maryland Medical Center and The Johns Hopkins Hospital. Dr. Moffett also completed a Master's in Public Health (Epidemiology) from the University of Texas Health Science Center at Houston. Dr. Moffett's interests include the use of cardiovascular medications in children, prevention of adverse drug events, and the impact of obesity on drug dosing in children.Dr. Moffett served as the Chair of the 21st Annual Meeting Planning Committee is Houston, Texas and has presented numerous times at PPAG.Mary Worthington, PharmD is a graduate of The Ohio State University with degrees of Bachelor of Science in Pharmacy and Doctor of Pharmacy. She completed a Residency in Hospital Pharmacy at Columbus Children's Hospital and a Residency in Pediatric Pharmacotherapy and Home Health Care at The University of Tennessee in Memphis. Dr. Worthington is currently an Asssociate Professor of Pharmacy Practice at the McWhorter School of Pharmacy at Samford University in Birmingham, Alabama. She holds a joint appointment with Children's of Alabama as a Pediatric Clinical Pharmacy Specialist. Dr. Worthington has been actively involved as a pediatric pharmacy practitioner for 25 years. Her current patient care activities are primarily in the area of general pediatrics.Dr. Worthington has been a member of the Pediatric Pharmacy Advocacy Group since 1997 serving on the Communication/Membership Committee. She served as Co-Chair of the Membership Committee this year, and on the 2009 International Symposium Planning Committee.

Greenhouse gas emissions associated with medical conferences have been associated with climate change, and the effects of climate change have been associated with an increased incidence of ophthalmic diseases. Identifying practical strategies associated with reducing these emissions may be warranted. To assess greenhouse gas emissions associated with in-person and virtual meetings of the American Academy of Ophthalmology (AAO) and to conduct mitigation analyses to suggest strategies to reduce future emissions. Quality improvement study in which attendee and conference data were used to estimate emissions from in-person (October 12 to October 15, 2019, San Francisco, California) and virtual (November 13 to November 15, 2020) AAO annual meetings for 35 104 attendees. The data were also used to perform mitigation analyses to assess whether meeting format alterations could be used to reduce future emissions. Data were analyzed from December 21, 2021, to April 18, 2022. Attendance at a selected meeting. Total attendance was 23 190 participants in 2019 and 11 914 participants in 2020. Greenhouse gas emissions produced by the in-person meeting were estimated by calculating the equivalent metric tons of carbon dioxide (CO2) associated with attendee transportation, attendee accommodations, and the conference venue. Emissions produced by the virtual meeting were estimated by calculating the equivalent metric tons of CO2 associated with attendees' computer use, network data transfer, and video-conferencing server use. Mitigation analyses simulated the association of changing the meeting location and format with reductions in emissions. In this analysis, the 2019 in-person meeting produced 39 910 metric tons of CO2 (1.73 metric tons of CO2 per capita), and the 2020 virtual meeting produced 38.6 metric tons of CO2 (0.003 metric tons of CO2 per capita). Mitigation analyses showed that holding a single in-person meeting in Chicago, Illinois, rather than San Francisco, California, could be associated with transportation-related emissions reductions of 19% (emissions for the San Francisco meeting, 38 993 metric tons of CO2; for the Chicago meeting, 31 616 metric tons of CO2). Holding multiple in-person meetings in separate regions could be associated with transportation-related emissions reductions of as much as 38% (emissions for the San Francisco meeting, 38 993 metric tons of CO2; for multiple meeting scenario 2, 24 165 metric tons of CO2). This study found that the AAO's 2019 in-person meeting was associated with substantially higher greenhouse gas emissions compared with the 2020 virtual meeting, primarily due to transportation-related emissions. Increasing the proportion of virtual participants, holding the meeting in locations chosen to minimize transportation-related emissions, or offering multiple regional meeting locations may reduce the carbon footprint of future meetings.

The burden of stroke on individuals, families, healthcare systems, and societies in Asia is enormous and increasing in relation to rapid sociodemographic and lifestyle changes in a large and diverse range of populations. However, challenges also present opportunities for experts from within and outside Asia to facilitate improvements in population health through advocacy, engagement, training, and the conduct and promotion of evidence-based strategies. With a total population that exceeds 4 billion, over half of the world’s population, increasing numbers of patients are accessing clinical services, technologies, and databases, and clinicians are gaining training, experience, and reliable information on a broad range of aspects of stroke care. Clinical research experience is improving through international links and fellowships, and health professionals from the region are eager to engage (and prove themselves) through participation in high-quality research and clinical practice. The Asia Pacific Stroke Organization (APSO) covers a vast and heterogenous geographical area, with much variability in language, governments, culture, historical links, socioeconomic development, and organization of health services. APSO seeks to improve the standard of stroke care in the whole region by improving communication and cooperation between stroke professionals and organizations in the region and peers in other regions, by means of annual congresses, workshops, and continued medical education. In the past year, we have achieved this through strengthened cooperation with other organizations such as the European Stroke Organization and the Asia-Oceanian Society for Neurorehabilitation and increased participation by nurses and other health professionals and had active consultation with nongovernmental organizations with shared commitments to those affected by stroke. APSO originated from an amalgamation of the Asian Stroke Forum and Asia Pacific Conference Against Stroke. Before September 2009, these organizations held large annual conferences, independently: Asian Stroke Forum, primarily based in Japan, had conferences in Tokyo and Kyoto, in 2005 and 2007, …

2021 update on the major activities of the International Society for Laboratory Hematology.

Emerging stronger than ever in 2021-2022

Learning outcomes The learning objectives (or expected learning objectives and outcomes) are to be achieved by linking them with particular concepts, theories and models. These include conducting a situational analysis of the social business, namely, Lilly Apartments’ Welfare Association; explaining the characteristics and mindset of the leadership, particularly the social entrepreneurial leaders; analysing the conflict among the team members; and designing strategic solutions for combating crises and attaining operations’ effectiveness. Case overview/synopsis Lilly Apartments’ Welfare Association Karachi was registered under the Act of 1860 of the Government of Pakistan. The members established this Association to oversee the affairs of the maintenance of the apartments, including the provision of utilities, particularly water, sanitation, lifts, generators, parking, security and a park with a small play area for children. The front-burner issue of the Association consisted of mis-governance (causing underperformance), including maintenance of buildings within apartments; recovery of funds from the past executive committee (EC) members due to their massive corruption; managing defaulters’ issues (i.e., the members who did not pay their monthly maintenance fees) and deficiency of funds; inefficient and corrupt practices of the majority of the employees, including one manager and two supervisors; and task-related and personal conflicts between the leadership members. The EC of the Association was elected every year and presently it had only four months left. The research design used for this case study involved conducting 12 interviews, four each involving EC members, former EC members and senior residents, which were analysed to learn the challenges and achievements of the Association. Moreover, pertinent records of the Association were reviewed. The canons of research ethics and soundness were applied. Complexity academic level This case study is suitable for the students of social entrepreneurship or strategy or strategy and leadership. The study level is for graduates in management science, including MBA and EMBA students. This case study is suitable for teaching at any point but ideally near the middle or end of the aforementioned courses. Supplementary materials Teaching notes are available for educators only. Subject code CSS 3: Entrepreneurship.